Similarly, a set of 11 potential therapeutic targets (AKT1, CCND1, CASP3, CTNNB1, EGF, EGFR, MYC, MAPK3, STAT3, TNF, TP53) was directly related to the KEGG pathway “hepatitis C” and interconnected with 23 compounds (SQ7, ZJ11, ZJ3, ZJ4, CBM9, CF2, CF3, QYS8, ZJ8, CL3, CL5, ZJ6, DSL4, DSL5, JTS1, TM12, XYS18, CL2, ZJ10, ZJ12, ZJ2, DSL6, ZZS1; Table S2). Here, KIR3DL2 is linked to hepatitis C virus infection.